SMi Source lesson Multiple Sclerosis: Treatment Strategies has the following microlearning topics
1. Introduction
2. Disease-Modifying Therapies
3. Immunosuppression vs. Immunomodulating
4. Self-Check: Long Term Goals of DMT
5. Self-Check: CHAMPS, ETOMS and BENEFIT Trials
6. Approved Parenteral Therapies for RRMS
7. Approved Parenteral Therapies for RRMS: Avonex
8. Approved Parenteral Therapies for RRMS: Betaseron
9. Approved Parenteral Therapies for RRMS: Extavia
10. Approved Parenteral Therapies for RRMS: Natalizumab (Tysabri, IV)
11. Additional Therapeutic Approaches
12. Mitoxantrone (Novantrone)
13. Self-Check: First-line Injectables
14. Self-Check: Interferon Beta (IFNβ)
15. Self-Check: SPMS and RRMS
16. Approved Oral Treatments for Multiple Sclerosis
17. Approved Oral Treatments for Multiple Sclerosis: Gilenya
18. Approved Oral Treatments for Multiple Sclerosis: Aubagio
19. Approved Oral Treatments for Multiple Sclerosis: Tecfidera
20. Self-Check: Oral MS Drug
21. Intensive Immune Suppression for Non-Responders
22. Self-Check: Immunosuppressant Drug
23. Self-Check: Inhibition of B Cell Activity
24. Treatment of Acute Relapses
25. Severe Relapses
26. Symptomatic Therapies
27. Self-Check: Therapeutic Plasma Exchange (TPE)
28. Summary: Goals of Disease Modifying Therapy (DMT)
29. Self-Check: Intense Immune Suppression Therapy
30. Self-Check: MS Treatment
31. Self-Check: Disease Modifying Therapies (DMTs)
32. Self-Check: FDA Approved Drug
